Your browser is no longer supported. Please, upgrade your browser.
STXS Stereotaxis, Inc. daily Stock Chart
Stereotaxis, Inc.
Index- P/E- EPS (ttm)-0.09 Insider Own2.20% Shs Outstand66.72M Perf Week5.15%
Market Cap299.57M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float51.29M Perf Month21.68%
Income-5.50M PEG- EPS next Q- Inst Own39.30% Short Float0.50% Perf Quarter34.43%
Sales29.30M P/S10.22 EPS this Y92.20% Inst Trans43.14% Short Ratio1.69 Perf Half Y65.07%
Book/sh0.35 P/B12.83 EPS next Y- ROA-20.90% Target Price- Perf Year227.74%
Cash/sh0.48 P/C9.45 EPS next 5Y- ROE-99.40% 52W Range1.01 - 4.75 Perf YTD315.36%
Dividend- P/FCF- EPS past 5Y66.50% ROI-189.00% 52W High-5.47% Beta1.64
Dividend %- Quick Ratio3.30 Sales past 5Y-5.10% Gross Margin80.10% 52W Low344.55% ATR0.21
Employees133 Current Ratio3.40 Sales Q/Q7.90% Oper. Margin-14.40% RSI (14)77.41 Volatility4.04% 6.13%
OptionableNo Debt/Eq0.00 EPS Q/Q39.10% Profit Margin-18.80% Rel Volume1.20 Prev Close4.40
ShortableYes LT Debt/Eq0.00 EarningsNov 18 BMO Payout- Avg Volume149.94K Price4.49
Recom- SMA2016.96% SMA5023.20% SMA20061.76% Volume179,259 Change2.05%
Dec-04-19 09:00AM  Stereotaxis CEO to Present at the 12th Annual LD Micro Main Event Investor Conference GlobeNewswire
02:00AM  Edited Transcript of STXS earnings conference call or presentation 14-Nov-19 2:00pm GMT Thomson Reuters StreetEvents
Nov-22-19 09:00AM  Stereotaxis CEO to Present at the 12th Annual BIOMEDevice San Jose Conference GlobeNewswire
Nov-14-19 08:00AM  Stereotaxis Reports 2019 Third Quarter Financial Results GlobeNewswire
Nov-08-19 09:00AM  Stereotaxis and Catheter Precision Combine Robotic Navigation and Preoperative Arrhythmia Localization to Treat Cardiac Arrhythmias GlobeNewswire
Nov-07-19 09:34AM  Could Stereotaxis, Inc.'s (NYSEMKT:STXS) Investor Composition Influence The Stock Price? Simply Wall St.
Nov-06-19 09:00AM  Stereotaxis to Report Third Quarter 2019 Financial Results on November 14, 2019 GlobeNewswire
Nov-05-19 09:00AM  Stereotaxis and inHEART Combine Robotic Precision and Advanced Preoperative 3D Mapping to Treat Cardiac Arrhythmias GlobeNewswire
Nov-01-19 09:00AM  Stereotaxis and ADAS 3D Combine Robotic Precision and Advanced Preoperative Substrate Mapping to Treat Cardiac Arrhythmias GlobeNewswire
Oct-09-19 06:18PM  This Hedge Fund Returns 22% Annually, Here Are Its Latest Picks Insider Monkey +7.02%
Sep-16-19 05:00PM  Stereotaxis Announces CFO Transition GlobeNewswire +16.44%
Sep-03-19 04:05PM  Stereotaxis Announces Uplisting to NYSE American GlobeNewswire +5.06%
Aug-29-19 08:05PM  Edited Transcript of STXS earnings conference call or presentation 8-Aug-19 1:00pm GMT Thomson Reuters StreetEvents
Aug-08-19 08:05AM  Stereotaxis Reports 2019 Second Quarter Financial Results GlobeNewswire +27.78%
08:00AM  Stereotaxis Announces $25 Million Private Placement GlobeNewswire
Aug-07-19 04:05PM  Stereotaxis to Report Second Quarter 2019 Financial Results on August 8, 2019 GlobeNewswire
Jul-31-19 09:00AM  Society for Cardiac Robotic Navigation to Showcase Stereotaxis Clinical Value & Technology GlobeNewswire
Jun-18-19 09:00AM  Stereotaxis Announces the First Graduating Class of the Robotic Electrophysiology Fellows Program GlobeNewswire
May-15-19 02:36PM  Edited Transcript of STXS earnings conference call or presentation 9-May-19 1:00pm GMT Thomson Reuters StreetEvents
May-09-19 08:04AM  Stereotaxis Announces Next Generation Robotic Magnetic Navigation System and Imaging System GlobeNewswire +6.50%
08:02AM  Stereotaxis and Osypka Enter Strategic Collaboration to Advance Robotic Catheter Technology GlobeNewswire
08:00AM  Stereotaxis Reports 2019 First Quarter Financial & Operational Results GlobeNewswire
Apr-29-19 09:00AM  Stereotaxis to Showcase Innovation and Technology at Heart Rhythm 2019 and Report First Quarter 2019 Financial Results on May 8-9, 2019 GlobeNewswire
Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.